European Survey on Heart Disease Prevention
European Survey of Cardiovascular Disease Prevention, Diabetes and Chronic Kidney Disease (EUROASPIRE VI)
Recruiting
Observational Study
Coronary Disease
Acute Coronary Syndrome
Unstable Angina
ST Elevation Myocardial Infarction
Non-ST Elevation Myocardial Infarction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 8,000 (estimated)
- Sponsor
- European Society of Cardiology · Research network
Who this trial is looking for
This trial is looking for patients with heart conditions or those at high risk of heart disease. Participants will share their experiences with healthcare providers about their treatment and care over the past few months.
Are You a Good Fit for This Trial?
You may be able to join if
- I am at least 18 years old.
- I have signed an informed consent.
- At least 6 months have passed since my heart event.
- I have had a heart-related event like a heart attack or unstable angina.
- I am at high risk for heart disease and am taking medications for it.
You may not be able to join if
- I live outside the specified geographic areas.
- I was admitted to a hospital outside the specified area.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to provide a unique European picture of preventive action by cardiologists, other specialists and primary care physicians looking after patients with coronary heart disease (CHD), individuals at high cardiovascular disease risk and all those with hypertension, dyslipidaemia (including familial hypercholesterolaemia), diabetes and dysglycaemia and chronic kid…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients having signed an informed Consent
* Patients aged from 18 years old at the time of identification
* At least six and at most 24 months elapsed between the index event (the recruiting diagnostic or treatment criteria below) and the date of interview
* Patients meeting …
Contacts